Guangzhou Wondfo Biotech (SHE:300482) received approval to market four SAFElife fentanyl urine tests in the US, according to an Aug. 16 disclosure on the Shenzhen Stock Exchange.
The US Food & Drug Administration handed down 510(k) clearances to the Chinese biotechnology firm's Fentanyl Urine Home Test (Cassette), T-Dip Fentanyl Urine Home Test (Dip Card), Fentanyl (FTY) Urine Test Cassette and T-Dip Fentanyl (FTY) Urine Test Panel.
The products can be purchased without the need for prescription, the disclosure added.
Shares of the company dropped less than 5% in recent trade.
Price (RMB): ¥22.01, Change: ¥-1.1, Percent Change: -4.88%
Comments